Inmune Bio (INMB) Receivables - Other (2021 - 2025)
Inmune Bio's Receivables - Other history spans 5 years, with the latest figure at $760000.0 for Q3 2025.
- For Q3 2025, Receivables - Other rose 39.45% year-over-year to $760000.0; the TTM value through Sep 2025 reached $760000.0, up 39.45%, while the annual FY2024 figure was $228000.0, 57.54% down from the prior year.
- Receivables - Other for Q3 2025 was $760000.0 at Inmune Bio, up from $550000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $760000.0 in Q3 2025 and bottomed at $100000.0 in Q3 2022.
- The 5-year median for Receivables - Other is $362000.0 (2022), against an average of $389384.6.
- The largest annual shift saw Receivables - Other skyrocketed 48.34% in 2023 before it crashed 76.12% in 2025.
- A 5-year view of Receivables - Other shows it stood at $300000.0 in 2021, then increased by 20.67% to $362000.0 in 2022, then surged by 48.34% to $537000.0 in 2023, then plummeted by 57.54% to $228000.0 in 2024, then surged by 233.33% to $760000.0 in 2025.
- Per Business Quant, the three most recent readings for INMB's Receivables - Other are $760000.0 (Q3 2025), $550000.0 (Q2 2025), and $133000.0 (Q1 2025).